These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 17395135)
1. The therapy of congenital myasthenic syndromes. Engel AG Neurotherapeutics; 2007 Apr; 4(2):252-7. PubMed ID: 17395135 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for congenital myasthenic syndromes. Lee M; Beeson D; Palace J Ann N Y Acad Sci; 2018 Jan; 1412(1):129-136. PubMed ID: 29381222 [TBL] [Abstract][Full Text] [Related]
7. [Congenital myasthenic syndromes with kinetic abnormalities of the acetylcholine receptor]. Islam Kediha M; Tazir M; Sternberg D; Eymard B; Ali Pacha L Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():58-63. PubMed ID: 37975772 [TBL] [Abstract][Full Text] [Related]
8. A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. Chaouch A; Müller JS; Guergueltcheva V; Dusl M; Schara U; Rakocević-Stojanović V; Lindberg C; Scola RH; Werneck LC; Colomer J; Nascimento A; Vilchez JJ; Muelas N; Argov Z; Abicht A; Lochmüller H J Neurol; 2012 Mar; 259(3):474-81. PubMed ID: 21822932 [TBL] [Abstract][Full Text] [Related]
9. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. Ohno K; Ohkawara B; Shen XM; Selcen D; Engel AG Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835142 [TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches. Schara U; Della Marina A; Abicht A Neuropediatrics; 2012 Aug; 43(4):184-93. PubMed ID: 22911480 [TBL] [Abstract][Full Text] [Related]
11. Current status of the congenital myasthenic syndromes. Engel AG Neuromuscul Disord; 2012 Feb; 22(2):99-111. PubMed ID: 22104196 [TBL] [Abstract][Full Text] [Related]
14. The spectrum of congenital myasthenic syndromes. Engel AG; Ohno K; Sine SM Mol Neurobiol; 2002; 26(2-3):347-67. PubMed ID: 12428764 [TBL] [Abstract][Full Text] [Related]
15. [Congenital myasthenic syndromes in childhood: Drug therapeutic strategies]. de la Vaissière S; Toutain A; Chêne MA; Lagrue E; Cantagrel S; Provost S; Eymard B; Castelnau P Arch Pediatr; 2015 Jul; 22(7):724-8. PubMed ID: 26028221 [TBL] [Abstract][Full Text] [Related]
16. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience]. Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D; Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772 [TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndromes in 2012. Engel AG Curr Neurol Neurosci Rep; 2012 Feb; 12(1):92-101. PubMed ID: 21997714 [TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndromes and the formation of the neuromuscular junction. Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858 [TBL] [Abstract][Full Text] [Related]
20. Congenital myasthenic syndromes: A diverse array of molecular targets. Engel AG; Ohno K; Sine SM J Neurocytol; 2003; 32(5-8):1017-37. PubMed ID: 15034283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]